Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin is a research paper published in Antimicrobial Agents and Chemotherapy (2025). On theSindex it has a DataRank of 0.189. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0244
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
Paratek Pharmaceuticals
Grant: G0505124
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: 2R01AI139261
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: T32 AI141349
NIAID NIH HHS
Grant: R01 AI139261
University of Houston New Investigator Award
MeSH Terms
Keywords